Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Non-Current Debt (2017 - 2019)

AC Immune has reported Non-Current Debt over the past 3 years, most recently at $301440.6 for Q3 2019.

  • Quarterly Non-Current Debt changed N/A to $301440.6 in Q3 2019 from the year-ago period, while the trailing twelve-month figure was $301440.6 through Sep 2019, changed N/A year-over-year, with the annual reading at $186899.3 for FY2018, 62.67% down from the prior year.
  • Non-Current Debt was $301440.6 for Q3 2019 at AC Immune, up from $255.31 in the prior quarter.
  • Over five years, Non-Current Debt peaked at $500708.2 in Q4 2017 and troughed at $255.31 in Q2 2019.
  • The 3-year median for Non-Current Debt is $196427.9 (2017), against an average of $229068.6.
  • The largest YoY upside for Non-Current Debt was 62.67% in 2018 against a maximum downside of 62.67% in 2018.
  • A 3-year view of Non-Current Debt shows it stood at $500708.2 in 2017, then tumbled by 62.67% to $186899.3 in 2018, then skyrocketed by 61.29% to $301440.6 in 2019.
  • Per Business Quant, the three most recent readings for ACIU's Non-Current Debt are $301440.6 (Q3 2019), $255.31 (Q2 2019), and $225914.1 (Q1 2019).